Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT03446261
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Registry
-
NCT03446261
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03446261. Randomized; no masking; primary purpose treatment. Start 2018-02-23 (actual); primary completion 2019-03-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Rosuvamibe® Tab
- Intervention (Drug)
- Monorova® Tab
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct03446261- Content hash
1aeed12610238e87b43d270143cecef32c5a7459536a6e7eae10b285ec23a059